Recommended

Find out more on ‘AI & Informatics: Drug discovery and development’ in our exclusive report
Download your complimentary copy of our latest digital journal
Free membership: sign up today to access all of our exclusive content
Hear from industry leaders in our upcoming webinars – reserve your place today!
article

Screening In-Depth Focus 2017

Posted: 5 June 2017 | | No comments yet

Included in this Screening In-Depth Focus: Phenotypic and target-based screening; Killing cancer cells using clinical drug resistance; Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool…

Screening in-depth focus digital issue #2 2017
  • Phenotypic and target-based screening – complementary or competing?
    Sheraz Gul, Fraunhofer-IME SP
  • Using clinical drug resistance to kill cancer cells
    Howard Fearnhead, NUI Galway and Sheraz Gul, Fraunhofer-IME SP
  • Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool
    Mahfoozur Rahman, Sam Higginbottom University of Agriculture, Technology & Sciences; Sarwar Beg, University Institute of Pharmaceutical Sciences; Imran Kazmi, Glocal School of Pharmacy; Amita Verma, Shalom Institute of Health and Allied sciences; Firoz Anwar, King Abdulaziz University; Vikas Kumar, Shalom Institute of Health and Allied sciences

This Screening In-Depth Focus is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here